(Q85776181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Who dies from prostate cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

A Patrikidou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Y Loriot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

J-C Eymard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

L Albiges

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

C Massard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

E Ileana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Di Palma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

B Escudier

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K Fizazi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

14 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

348-352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2014.35

21 February 2020

exact match

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Tumour Features in the Control and Screening Arm of A Randomized Trial of Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Prostate-cancer mortality at 11 years of follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Causes of death in men with prostate cancer: an analysis of 50,000 men from the Thames Cancer Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

What do prostate cancer patients die of?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Temporal trends in cause of death among Swedish and US men with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Natural History of Early, Localized Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Adjuvant mitozantrone chemotherapy in advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Tracking the clonal origin of lethal prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Circulating and disseminated tumor cells in the management of advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Mechanisms of Metastatic Tumor Dormancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.35

31 March 2020

Identifiers

DOI

10.1038/PCAN.2014.35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25311767%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 February 2020

0 references

1 reference